Literature DB >> 34704414

Simultaneous determination of related substances in entecavir film-coated tablet by high performance liquid chromatography.

Yi Zhang1, Hong Yuan1.   

Abstract

: To establish a high performance liquid chromatography method to simultaneously quantify eight related substances in entecavir film-coated tablets.According to USP40 and YBH33292005 standards, a high performance liquid chromatography (HPLC) method for simultaneous determination of 8 related substance in entecavir film-coated tablets was established and validated. The column was WATERS C18 (250 mm the mobile phase A was water-acetonitrile-trifluoroacetic acid (990∶10∶1), the mobile phase B was water-acetonitrile-trifluoroacetic acid (700∶300∶1) with gradient elution and ultraviolet-visible light detector, detection wavelength at 254 nm and column temperature of The resolution between entecavir and each impurity peak was more than 1.5, and each impurity had a good linear relationship with the peak area in the linear range. The limits of detection and quantification, precision, stability, durability, specificity, met the verification requirements. The HPLC method established in this study can be used for simultaneous determination of 8 related substance in entecavir film-coated tablets.

Entities:  

Keywords:  Chromatography, liquid; Entecavir; Film-coated tablet; Related substance; Ultraviolet-visible light detector

Mesh:

Substances:

Year:  2021        PMID: 34704414      PMCID: PMC8714476          DOI: 10.3724/zdxbyxb-2021-0247

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  2 in total

1.  Improving sleep/wake detection via boundary adaptation for respiratory spectral features.

Authors:  Xi Long; Reinder Haakma; Jerome Rolink; Pedro Fonseca; Ronald M Aarts
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015

Review 2.  Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

Authors:  Anastasia Rivkin
Journal:  Drugs Today (Barc)       Date:  2007-04       Impact factor: 2.245

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.